Canaccord raised the firm’s price target on HealthStream to $28 from $27 and keeps a Hold rating on the shares. The firm said results indicated steady performance despite two headwinds including one-time items which negatively impacted financial performance and the bankruptcy of Steward Health.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HSTM: